The World Health Organization (WHO) welcomes the results from NAMSAL (New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-income countries), a study conducted in Cameroon by the French Agency for Research on AIDS and Viral Hepatitis (ANRS). The study aims to compare the efficacy of two first-line treatments for HIV infection in more than 600 participants.